Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 1
2004 1
2005 1
2006 4
2007 2
2008 1
2010 2
2011 1
2012 3
2013 4
2014 8
2015 2
2016 7
2017 6
2018 2
2019 5
2020 7
2021 6
2022 8
2023 5
2024 8
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for joao c
Search for Joco C instead (3 results)
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Hillengass J, Usmani S, Rajkumar SV, Durie BGM, Mateos MV, Lonial S, Joao C, Anderson KC, García-Sanz R, Riva E, Du J, van de Donk N, Berdeja JG, Terpos E, Zamagni E, Kyle RA, San Miguel J, Goldschmidt H, Giralt S, Kumar S, Raje N, Ludwig H, Ocio E, Schots R, Einsele H, Schjesvold F, Chen WM, Abildgaard N, Lipe BC, Dytfeld D, Wirk BM, Drake M, Cavo M, Lahuerta JJ, Lentzsch S. Hillengass J, et al. Among authors: joao c. Lancet Oncol. 2019 Jun;20(6):e302-e312. doi: 10.1016/S1470-2045(19)30309-2. Lancet Oncol. 2019. PMID: 31162104 Review.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, Mikhael J, Terpos E, Schjesvold F, Martin T, Yong K, Durie BGM, Facon T, Jurczyszyn A, Sidana S, Raje N, van de Donk N, Lonial S, Cavo M, Kristinsson SY, Lentzsch S, Hajek R, Anderson KC, João C, Einsele H, Sonneveld P, Engelhardt M, Fonseca R, Vangsted A, Weisel K, Baz R, Hungria V, Berdeja JG, Leal da Costa F, Maiolino A, Waage A, Vesole DH, Ocio EM, Quach H, Driessen C, Bladé J, Leleu X, Riva E, Bergsagel PL, Hou J, Chng WJ, Mellqvist UH, Dytfeld D, Harousseau JL, Goldschmidt H, Laubach J, Munshi NC, Gay F, Beksac M, Costa LJ, Kaiser M, Hari P, Boccadoro M, Usmani SZ, Zweegman S, Holstein S, Sezer O, Harrison S, Nahi H, Cook G, Mateos MV, Rajkumar SV, Dimopoulos MA, Richardson PG. Moreau P, et al. Among authors: joao c. Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7. Lancet Oncol. 2021. PMID: 33662288 Review.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.
Dreyling M, Jurczak W, Jerkeman M, Silva RS, Rusconi C, Trneny M, Offner F, Caballero D, Joao C, Witzens-Harig M, Hess G, Bence-Bruckler I, Cho SG, Bothos J, Goldberg JD, Enny C, Traina S, Balasubramanian S, Bandyopadhyay N, Sun S, Vermeulen J, Rizo A, Rule S. Dreyling M, et al. Among authors: joao c. Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7. Lancet. 2016. PMID: 26673811 Clinical Trial.
Boosting Immunity against Multiple Myeloma.
Lopes R, Ferreira BV, Caetano J, Barahona F, Carneiro EA, João C. Lopes R, et al. Among authors: joao c. Cancers (Basel). 2021 Mar 11;13(6):1221. doi: 10.3390/cancers13061221. Cancers (Basel). 2021. PMID: 33799565 Free PMC article. Review.
Global treatment of haemorrhoids-A worldwide snapshot audit conducted by the International Society of University Colon and Rectal Surgeons.
Samalavicius NE, Gupta RK, Nunoo-Mensah J, Fortunato R, Lohsiriwat V, Khanal B, Kumar A, Sah B, Cerkauskaite D, Dulskas A; 2023 International Society of Universities of Colon and Rectal Surgeons (ISUCRS) Collaborating Group. Samalavicius NE, et al. Colorectal Dis. 2024 Oct;26(10):1797-1804. doi: 10.1111/codi.17140. Epub 2024 Aug 21. Colorectal Dis. 2024. PMID: 39169548
Prevalence of asthma in Portuguese adults - the EPI-ASTHMA study, a nationwide population-based survey.
Brito D, Jácome C, Bulhões C, Barbosa MJ, Pina N, Alves da Silva A, João C, Gomes D, Lopes F, Quelhas-Santos J, Amorim L, Rodrigues M, Pardal M, Teixeira PM, Jacinto T, Cruz AM, Pereira AM, Marques A, Sousa-Pinto B, Vicente C, Ferreira E, Alves L, Fernandes MI, Vieira R, Amaral R, Sousa R, Costa R, Castanho T, Bernardo F, Correia-de-Sousa J, Fonseca JA; AEPI-ASTHMA Group. Brito D, et al. Among authors: joao c. Pulmonology. 2025 Dec 31;31(1):2466920. doi: 10.1080/25310429.2025.2466920. Epub 2025 Mar 17. Pulmonology. 2025. PMID: 40094487 Free article.
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
Lopes R, Caetano J, Ferreira B, Barahona F, Carneiro EA, João C. Lopes R, et al. Among authors: joao c. Cancers (Basel). 2021 Feb 5;13(4):625. doi: 10.3390/cancers13040625. Cancers (Basel). 2021. PMID: 33562441 Free PMC article. Review.
77 results